Evidera operates as a wholly owned subsidiary of Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO). Evidera was created in 2013 as an independent company under the ownership of Symphony Technology Group (STG) following the acquisition of long-standing health economics, outcomes research, market access, epidemiology and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group and Archimedes. Since it was formed, Evidera has worked with all of the top 20 biopharma companies, and is a preferred provider for most of the top 50. Evidera scientists and consultants publish more than 150 peer-reviewed articles per year and have more than 1,100 studies in progress across all major therapeutic areas. Evidera’s 300 researchers and consultants have expertise working in all developed and many developing countries.
Show more

Employee Rating

3.9
TypeSubsidiary
HQBethesda, US
Founded2013
Websiteevidera.com
Evidera was founded in 2013 and is headquartered in Bethesda, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Evidera

J. Jaime Caro

J. Jaime Caro

MDCM, FRCPC, FACP, Chief Scientist
Denis Getsios

Denis Getsios

Vice President and General Manager, Modeling and Simulation
Nancy Kline Leidy

Nancy Kline Leidy

PhD, Senior Vice President, Scientific Affairs and Patient-Centered Outcomes Research
Lowell Price

Lowell Price

Vice President, Global Head of Commercial
Margaret K. Vernon

Margaret K. Vernon

PhD, Vice President and General Manager, Patient-Centered Research
Radek Wasiak

Radek Wasiak

PhD, MA, MSc, Vice President, Global Head, Peri- & Post-Approval Studies
Show more

Evidera Office Locations

Evidera has offices in Bethesda, Seattle, San Francisco, Waltham and in 4 other locations
Bethesda, US (HQ)
1400 7101 Wisconsin Ave
Harrisburg, US
503 225 Market St
San Francisco, US
650 450 Sansome St
Seattle, US
510 1417 4th Ave
Waltham, US
500 Totten Pond Rd
Montréal, CA
Route Transcanadienne
Show all (8)
Report incorrect company information

Evidera Financials and Metrics

Summary Metrics

Founding Date

2013
Report incorrect company information

Evidera Online and Social Media Presence

Embed Graph
Report incorrect company information

Evidera News and Updates

Biosimulation Market is Projected to Reach US$ 1,750 Mn by 2022

The global biosimulation market is forecasted to reach a figure of about US$ 1,750 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Evidera Company Life and Culture

Report incorrect company information

Evidera Frequently Asked Questions

  • When was Evidera founded?

    Evidera was founded in 2013.

  • Who are Evidera key executives?

    Evidera's key executives are J. Jaime Caro, Denis Getsios and Nancy Kline Leidy.

  • Who are Evidera competitors?

    Competitors of Evidera include Foundation Medicine, Optibiotix Health and Biotix.

  • Where is Evidera headquarters?

    Evidera headquarters is located at 1400 7101 Wisconsin Ave, Bethesda.

  • Where are Evidera offices?

    Evidera has offices in Bethesda, Seattle, San Francisco, Waltham and in 4 other locations.

  • How many offices does Evidera have?

    Evidera has 8 offices.